FDA issued a Warning Letter to Porton Biopharma Limited on 1/19/2017 as a result of this inspection.
483 Porton Biopharma Mar 2016

483 Porton Biopharma Mar 2016

Francis Guidry FDA$119.00 - Available Now

FDA investigators audited the Porton Biopharma - Salisbury, United Kingdom facility and issued inspectional observations (via FDA 483) on 18 Mar 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Mar 2016
  • Location: Salisbury, United Kingdom
  • FEI: 3011691465
Add To Cart